Drug distributor Farmaceutica Remedia (ticker: RMAH) reported a profit of 606,503 lei (€143,000) for the third quarter this year, after 1.07 million lei loss in Apr-Jul 2009 period.
The distributor’s turnover climbed 7.2% to 36.6 million lei (€8.6 million), while revenues increased by 3% to 37.2 million lei (€8.8 million), compared to second quarter this year.
Costs fell 3% to 36.6 million lei (€8.6 million) compared to previous quarter.
Farmaceutica Remedia said it expects a full-year net profit of 2 million lei (€0.47 million), after year-ago loss, on 14.5% increase in sales to 150 million lei.
The company has a share capital of 9.85 million lei, divided into 98.5 million shares at a face value of 0.10 lei.
The majority shareholder of the company is also the chairman of the distributor, Valentin Norbert Tarus with 66.54% stake, while the Romanian branch of the German-based AHG Industry – AHG Simcor Industry with 16.5%.
The market value of the company is 17.71 million lei (€4.12 million), according to yesterday’s closing quote of 0.167lei/share.
Article comments "Farmaceutica Remedia swings back to profit in Q3"
Opinia cititorilor nostri este importanta pentru noi, Wall-Street incurajand publicarea comentariilor voastre. Pe site urmeaza sa isi gaseasca locul numai comentariile pertinente, on-topic, prezentate intr-un limbaj civilizat, fara atacuri la persoane / institutii. Ne rezervam dreptul de a elimina orice comentariu care nu corespunde acestor principii, precum si de a restrictiona accesul la comentarii utilizatorilor care comit abuzuri grave sau repetate.
Wall-Street pe Facebook
Wall-Street pe Twitter
Wall-Street prin RSS